Charles Schwab Investment Management Inc Pulse Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 172,407 shares of PLSE stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172,407
Previous 149,639
15.22%
Holding current value
$2.6 Million
Previous $2.41 Million
8.06%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PLSE
# of Institutions
89Shares Held
5.83MCall Options Held
37.5KPut Options Held
33.6K-
Vanguard Group Inc Valley Forge, PA1.22MShares$18.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.15MShares$17.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC784KShares$11.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA499KShares$7.54 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$6.33 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $561M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...